Elevance Health, Inc.
ELV
$386.85
$4.621.21%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.36% | 10.30% | 14.10% | 11.93% | 9.66% |
| Total Other Revenue | 5.82% | 5.32% | 5.56% | 12.09% | 13.02% |
| Total Revenue | 6.27% | 9.44% | 12.62% | 11.96% | 10.21% |
| Cost of Revenue | 7.49% | 12.24% | 16.19% | 14.56% | 12.52% |
| Gross Profit | 2.92% | 2.16% | 3.37% | 5.24% | 4.37% |
| SG&A Expenses | 8.49% | 7.72% | 8.19% | 12.83% | 9.01% |
| Depreciation & Amortization | -9.27% | -5.49% | 8.28% | 4.38% | -14.57% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.66% | 11.12% | 14.31% | 14.13% | 11.59% |
| Operating Income | -20.43% | -20.23% | -15.88% | -20.21% | -10.81% |
| Income Before Tax | -17.06% | -19.90% | -15.11% | -14.44% | -17.62% |
| Income Tax Expenses | -46.77% | -47.20% | -45.73% | -17.64% | -9.48% |
| Earnings from Continuing Operations | -7.52% | -11.33% | -5.19% | -13.48% | -19.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 45.45% | -45.45% | -88.89% | -82.76% | 10.00% |
| Net Income | -7.41% | -11.39% | -5.32% | -13.79% | -19.89% |
| EBIT | -20.43% | -20.23% | -15.88% | -20.21% | -10.81% |
| EBITDA | -17.35% | -16.83% | -12.55% | -16.95% | -9.75% |
| EPS Basic | -4.30% | -8.47% | -2.23% | -11.07% | -17.77% |
| Normalized Basic EPS | -22.26% | -22.53% | -18.17% | -23.15% | -12.60% |
| EPS Diluted | -4.27% | -8.28% | -1.92% | -10.83% | -17.61% |
| Normalized Diluted EPS | -22.22% | -22.40% | -17.98% | -23.00% | -12.51% |
| Average Basic Shares Outstanding | -3.58% | -3.42% | -3.36% | -2.85% | -2.29% |
| Average Diluted Shares Outstanding | -3.64% | -3.58% | -3.57% | -3.06% | -2.42% |
| Dividend Per Share | 2.69% | 3.79% | 4.91% | 6.12% | 7.40% |
| Payout Ratio | 0.07% | 0.13% | 0.07% | 0.19% | 0.31% |